Jazz PharmaceuticalsvsMerck & Company

JAZZ and MRK stock compared: price, dividend, valuation and results, from SEC filings.

JAZZ

Jazz Pharmaceuticals plc

$247.77

Value $15.5B

+2.93%
JAZZ's page

MRK

Merck & Company, Inc.

$137.78

Value $341B

-3.90%
MRK's page

Jazz Pharmaceuticals (JAZZ) has a market value of $15.5B and Merck & Company (MRK) $341B. Over the last year, with dividends, JAZZ moved +45.7% and MRK +52.7%. The P/E is 75.5 for JAZZ and 138.9 for MRK. Dividend yield: JAZZ none, MRK 2.47%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JAZZ$15.5B

    MRK$341B

    MRK is 22 times JAZZ

  • Revenue, 12 months

    JAZZ$4.7B

    MRK$67.4B

    MRK is 14 times JAZZ

  • Net income, 12 months

    JAZZ$206M

    MRK$2.5B

    MRK is 12 times JAZZ

  • Operating margin

    JAZZ9.0%

    MRK–

  • ROIC

    JAZZ3.5%

    MRK3.9%

    0.4 points apart

  • P/E

    JAZZ75.5

    MRK138.9

    MRK is 1.8 times JAZZ

  • Dividend yield

    JAZZ0.0%

    MRK2.5%

    2.5 points apart

  • 5-year return

    JAZZ+86.2%

    MRK+94.3%

    8.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JAZZ+86.2%

MRK+94.3%

10015020020222023202420252026
Returns by period
PeriodJAZZWith dividendsMRKWith dividends
1 year since November 17, 2025+45.7%Price +45.7%+52.7%Price +48.4%
3 years since November 17, 2023+105.5%+27.1% a yearPrice +105.5%+48.4%+14.1% a yearPrice +35.4%
5 years since November 17, 2021+86.2%+13.2% a yearPrice +86.2%+94.3%+14.2% a yearPrice +66.8%
10 years since November 18, 2016+126.8%+8.5% a yearPrice +126.8%+216.6%+12.2% a yearPrice +133.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JAZZJazz PharmaceuticalsMRKMerck & Company

Valuation

JAZZMRK
Valuation
Price$247.77$137.78
Market value$15.5B$341B
Enterprise value (EV)$18.3B$385B
P/E75.5138.9
P/E, 5-year median–14.8
P/B3.77.6
EV/EBIT42.980.8
Free cash flow yield10.4%4.3%

Results and growth

JAZZMRK
Results and growth
Revenue, 12 months$4.7B$67.4B
Net income, 12 months$206M$2.5B
Free cash flow, 12 months$1.6B$14.7B
Earnings per share, 12 months$3.07$0.98
Revenue growth, year on year4.9%1.3%
Revenue growth a year, past+12.5%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

JAZZMRK
Margins and returns on capital
Gross margin–71.8%
Operating margin9.0%–
Net margin4.4%3.6%
ROIC3.5%3.9%
ROE4.7%5.2%

Balance sheet

JAZZMRK
Balance sheet
Cash$2.9B$9.7B
Total debt$5.6B$53.8B
Net debt / EBITDA5.85.7
Interest cover–2.4×

Dividends and buybacks

JAZZMRK
Dividends and buybacks
Dividend yield–2.5%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield0.8%1.5%
Shareholder yield0.8%4.0%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JAZZ or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Jazz Pharmaceuticals or Merck & Company?

By market value, Merck & Company ($341B) is about 21.9 times Jazz Pharmaceuticals ($15.5B), at today's prices.

How did JAZZ and MRK stock do over the last 10 years?

Since November 18, 2016, JAZZ's price moved +126.8% and MRK's +133.4%. With dividends: JAZZ +126.8% (+8.5% a year), MRK +216.6% (+12.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, JAZZ or MRK?

The dividend yield at today's price is none for Jazz Pharmaceuticals and 2.47% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of JAZZ and MRK?

At today's price, the P/E is 75.5 for JAZZ and 138.9 for MRK. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Jazz Pharmaceuticals or Merck & Company?

Over the last twelve months, the net margin was 4.4% for Jazz Pharmaceuticals and 3.6% for Merck & Company, and the operating margin 9.0% and –. Revenue was $4.7B and $67.4B.

Which is the better investment, Jazz Pharmaceuticals or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.